Table 1.
Variable | Full Sample (N = 596) |
Pre-COVID-19 Period (N = 300) |
During-COVID-19 Period (N = 296) |
---|---|---|---|
Gender | |||
Male | 317 (53.2%) | 147 (49.0%) | 170 (57.4%) |
Female | 277 (46.5%) | 152 (50.7%) | 125 (42.2%) |
Race/Ethnicity | |||
White/Non-Hispanic | 433 (72.7%) | 219 (73.0%) | 214 (72.3%) |
White/Hispanic | 30 (5.0%) | 16 (5.3%) | 14 (4.7%) |
Black/Non-Hispanic | 47 (7.9%) | 24(8.0%) | 23 (7.8%) |
Asian/Non-Hispanic | 51 (8.6%) | 23 (7.7%) | 28 (9.5%) |
Multiracial/Ethnicity | 35 (5.9%) | 18 (6.0%) | 17 (5.7%) |
Age | 37.81 (SD ± 10.72) | 37.41 (SD ± 10.49) | 38.22 (SD ± 10.95) |
Current Nicotine Use | |||
None | 467 (78.4%) | 229 (76.3%) | 238 (80.4%) |
Occasional | 7 (1.2%) | 2 (0.7%) | 5 (1.7%) |
Monthly | 5 (0.8%) | 1 (0.3%) | 4 (1.4%) |
Weekly | 17 (2.9%) | 8 (2.7%) | 9 (3.0%) |
Daily | 100 (16.8%) | 60 (20.0%) | 40 (13.5%) |
AUDIT Total | 3.78 (SD ± 5.03) | 3.93 (SD ± 4.85) | 3.63 (SD ± 5.21) |
EPSI Binge Eating Subscale Total | 8.01 (SD ± 6.28) | 8.64 (SD ± 6.50) | 7.36 (SD ± 5.99) |
Note. Abbreviations are SD (standard deviation); AUDIT (Alcohol Use Identification Test); EPSI (Eating Pathology Symptom Inventory).